Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC40A1 | Q9NP59 | 9/20 | 0.69 |
| ▸ | GLO1 | Q04760 | 7/20 | 0.46 |
| ▸ | CKS1B | P61024 | 3/20 | 0.43 |
| ▸ | SKP2 | Q13309 | 3/20 | 0.43 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26964128 | 1.00 | SLC40A1 (0.69) | SLC40A1GLO1CKS1BSKP2SLC22A12 | |
| SCHEMBL11995656 | 0.82 | SLC40A1 (1.00) | SLC40A1GLO1 | |
| SCHEMBL11995662 | 0.79 | SLC40A1 (1.00) | SLC40A1GLO1CKS1BSKP2MEN1 | |
| SCHEMBL11973205 | 0.76 | SLC40A1 (1.00) | SLC40A1GLO1CKS1BSKP2MEN1 | |
| SCHEMBL11995655 | 0.76 | SLC40A1 (1.00) | SLC40A1CKS1BSKP2MEN1KMT2A | |
| SCHEMBL11973789 | 0.73 | SLC40A1 (0.71) | SLC40A1CKS1BSKP2SLC22A12MEN1 | |
| SCHEMBL11973381 | 0.69 | SLC40A1 (0.65) | SLC40A1SLC22A12MEN1KMT2ATDP1 | |
| SCHEMBL30925524 | 0.69 | SLC40A1 (0.67) | SLC40A1GLO1CKS1BSKP2MEN1 | |
| SCHEMBL30925420 | 0.69 | SLC40A1 (0.67) | SLC40A1GLO1CKS1BSKP2MEN1 | |
| SCHEMBL11973601 | 0.69 | SLC40A1 (0.68) | SLC40A1MEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4291555-A1 | SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES | Celgene Corporation (US) | 2023-12-20 | — | — | EP | claimed |
| CN-116806218-A | Sulfonamide and its use for the treatment of parasitic helminth infections and diseases | 新基公司 | 2023-09-26 | — | — | CN | claimed |
| WO-2022173727-A1 | SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES | CELGENE CORPORATION (US) | 2022-08-18 | — | — | WO | claimed |
| EP-4291555-A1 | SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES | Celgene Corporation (US) | 2023-12-20 | — | — | EP | disclosed |
| CN-116806218-A | Sulfonamide and its use for the treatment of parasitic helminth infections and diseases | 新基公司 | 2023-09-26 | — | — | CN | disclosed |
| WO-2022173727-A1 | SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES | CELGENE CORPORATION (US) | 2022-08-18 | — | — | WO | disclosed |